Tobias Weiglein, MD, MBA, is a medical oncologist at the Department of Haematology and Oncology at the Ludwig Maximilians University of Munich, Campus Großhadern, Germany.
He started his career as a medical doctor in Munich in 2010. His clinical research focuses on the treatment of malignant lymphoma, especially mantle cell lymphoma and marginal zone lymphoma. Another area of interest lies in health care economics and future care for cancer patients in less developed rural areas. In 2015 he completed his specialisation in palliative care and in 2016 received his Master’s Degree in Health and Business Administration at the Friedrich Alexander University of Nürnberg. In 2018 he completed his training on primary psychosomatic health care.
Dr Weiglein is a member of the European Society for Medical Oncology (ESMO), the German Association of Hematology and Oncology (DGHO), the German Cancer Association (DKK), the German Association of Palliative Care (DGP), the German Working Group for internal Oncology (AIO) and the Tumor-Center Munich (TZM).